title: HIT on dialysis--when is it safe to re-challenge?
authors.forename: Andrew
authors.initials: A
authors.lastname: Davenport
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects; D001323:Autoantibodies / Q000276:immunology*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D005260:Female; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000139:chemically induced* / Q000276:immunology* / Q000517:prevention & control; D006435:Renal Dialysis / Q000009:adverse effects; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology* / Q000517:prevention & control; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D001323:Autoantibodies; D006493:Heparin